PL364798A1 - Sposób wykrywania N-końcowego proBNP - Google Patents

Sposób wykrywania N-końcowego proBNP

Info

Publication number
PL364798A1
PL364798A1 PL00364798A PL36479800A PL364798A1 PL 364798 A1 PL364798 A1 PL 364798A1 PL 00364798 A PL00364798 A PL 00364798A PL 36479800 A PL36479800 A PL 36479800A PL 364798 A1 PL364798 A1 PL 364798A1
Authority
PL
Poland
Prior art keywords
bnp
terminal pro
identifying
terminal probnp
recombinant
Prior art date
Application number
PL00364798A
Other languages
English (en)
Other versions
PL204235B1 (pl
Inventor
Johann Karl
Helmut Lill
Peter Stahl
Kerstin Krueger
Anneliese Borgya
Andreas Gallusser
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PL364798A1 publication Critical patent/PL364798A1/pl
Publication of PL204235B1 publication Critical patent/PL204235B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of Radiation (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
PL364798A 1999-01-29 2000-01-27 Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych PL204235B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903489 1999-01-29
DE19911044 1999-03-12
PCT/EP2000/000602 WO2000045176A2 (de) 1999-01-29 2000-01-27 VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP

Publications (2)

Publication Number Publication Date
PL364798A1 true PL364798A1 (pl) 2004-12-13
PL204235B1 PL204235B1 (pl) 2009-12-31

Family

ID=26051550

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364798A PL204235B1 (pl) 1999-01-29 2000-01-27 Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych

Country Status (21)

Country Link
US (1) US20070059767A1 (pl)
EP (2) EP1151304B9 (pl)
JP (1) JP3987284B2 (pl)
KR (1) KR100572542B1 (pl)
CN (2) CN101046478B (pl)
AT (2) ATE403158T1 (pl)
AU (1) AU758562B2 (pl)
CA (1) CA2359667C (pl)
CY (1) CY1108450T1 (pl)
DE (2) DE50015291D1 (pl)
DK (2) DK1698901T3 (pl)
ES (2) ES2312062T3 (pl)
HU (1) HU228625B1 (pl)
IL (2) IL144062A0 (pl)
NO (1) NO329866B1 (pl)
NZ (1) NZ512762A (pl)
PL (1) PL204235B1 (pl)
PT (1) PT1698901E (pl)
RU (1) RU2218568C2 (pl)
WO (1) WO2000045176A2 (pl)
ZA (1) ZA200106193B (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004105A (es) 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
GB0216191D0 (en) * 2002-07-11 2002-08-21 Univ Leicester Plasma urotensin in human heart failure
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US6960472B2 (en) * 2002-11-18 2005-11-01 Ottawa Heart Institute Research Corporation Monoclonal antibodies against N-Terminus proBNP
US20050287613A1 (en) * 2002-11-18 2005-12-29 George Jackowski Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
EP1562990B1 (en) 2002-11-18 2010-07-21 Syn X Pharma, Inc. Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
US20040096919A1 (en) 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
WO2004046181A1 (de) * 2002-11-20 2004-06-03 B.R.A.H.M.S Aktiengesellschaft Sandwich-immunoassay zur bestimmung bon proanp-teilpeptiden
US7767419B2 (en) * 2003-02-04 2010-08-03 Nexus Dx, Inc. Calibrator for NT-proBNP immunoassay
CN100497393C (zh) 2003-05-12 2009-06-10 霍夫曼-拉罗奇有限公司 用结合脑钠尿肽前体分子氨基酸41-46的单克隆抗体检测脑钠尿肽前体分子的方法
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
DE10355731A1 (de) 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
GB0329288D0 (en) 2003-12-18 2004-01-21 Inverness Medical Switzerland Monitoring method and apparatus
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FR2863269B1 (fr) * 2005-01-14 2006-05-26 Bio Rad Pasteur Peptides specifiques pour le diagnostic de l'insuffisance cardiaque
DE102005003687A1 (de) * 2005-01-26 2006-07-27 Sphingo Tec Gmbh Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
EP1722232A1 (en) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
EP1909207B1 (de) * 2006-09-11 2015-03-04 F.Hoffmann-La Roche Ag Messbereichserweiterung chromatografischer Schnellteste
EP1909206A1 (de) 2006-09-11 2008-04-09 Roche Diagnostics GmbH Messbereichserweiterung chromatografischer Schnellteste
DE102006060835A1 (de) * 2006-12-22 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP
CN106908603B (zh) * 2007-01-25 2019-04-02 霍夫曼-拉罗奇有限公司 Igfbp-7在心力衰竭评估中的用途
EP1970709B1 (en) * 2007-03-06 2013-07-10 Roche Diagnostics GmbH The use of BNP-type peptides for predicting the need for dialysis
JP5081930B2 (ja) 2007-03-08 2012-11-28 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｓｌｉｍ−１の使用
JP5198565B2 (ja) * 2007-08-30 2013-05-15 エフ．ホフマン−ラ ロシュ アーゲー 心疾患に関連する又は関連しないｇｄｆ−１５の上昇の区別のための手段及び方法
ES2526928T3 (es) 2008-04-30 2015-01-16 The Governing Council Of The University Of Toronto Uso de SFRP-3 en la evaluación de la insuficiencia cardíaca
CN102549436A (zh) 2009-07-27 2012-07-04 霍夫曼-拉罗奇有限公司 mimecan在评价心力衰竭中的用途
EP2478367B2 (en) 2009-09-14 2018-04-04 Koninklijke Philips N.V. Highly sensitive immunoassay with large particle labels
CN101819205A (zh) * 2010-06-03 2010-09-01 中国人民解放军第三军医大学 人n端b型利钠肽原免疫分析试剂盒及其制备方法
US8778699B2 (en) * 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
AU2012262154B2 (en) 2011-05-31 2016-08-04 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
CN102692512A (zh) * 2012-06-26 2012-09-26 南京基蛋生物科技有限公司 NT-proBNP双抗夹心快速检测试剂盒
CN109678958B (zh) * 2019-01-31 2022-03-18 重庆探生科技有限公司 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用
EP4014041A1 (en) 2019-08-13 2022-06-22 Gentian AS Highly sensitive particle enhanced assay for the quantification of nt-probnp
EP4409297B1 (en) 2021-10-01 2025-01-29 Gentian AS Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
DE3509958A1 (de) * 1985-03-20 1986-09-25 Bayer Ag, 5090 Leverkusen Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
WO2008091207A1 (en) * 2007-01-26 2008-07-31 Telefonaktiebolaget Lm Ericsson (Publ) Border region processing in images

Also Published As

Publication number Publication date
CN1339107A (zh) 2002-03-06
JP3987284B2 (ja) 2007-10-03
EP1698901B1 (de) 2008-07-30
ES2312062T3 (es) 2009-02-16
CN1327228C (zh) 2007-07-18
KR20010101874A (ko) 2001-11-15
DE50015291D1 (de) 2008-09-11
CA2359667A1 (en) 2000-08-03
PL204235B1 (pl) 2009-12-31
EP1698901A1 (de) 2006-09-06
ATE403158T1 (de) 2008-08-15
AU2545100A (en) 2000-08-18
CY1108450T1 (el) 2014-04-09
WO2000045176A2 (de) 2000-08-03
DK1698901T3 (da) 2008-12-08
AU758562B2 (en) 2003-03-27
HU228625B1 (en) 2013-04-29
HUP0105195A2 (hu) 2002-04-29
IL144062A (en) 2007-09-20
NO20013698D0 (no) 2001-07-27
ZA200106193B (en) 2002-05-02
EP1151304B9 (de) 2008-06-04
NZ512762A (en) 2003-02-28
ATE373826T1 (de) 2007-10-15
HUP0105195A3 (en) 2005-11-28
DK1151304T3 (da) 2008-01-28
DE50014666D1 (de) 2007-10-31
IL144062A0 (en) 2002-04-21
US20070059767A1 (en) 2007-03-15
NO329866B1 (no) 2011-01-17
EP1151304A2 (de) 2001-11-07
PT1698901E (pt) 2008-10-08
WO2000045176A3 (de) 2001-07-26
CA2359667C (en) 2009-10-20
RU2218568C2 (ru) 2003-12-10
ES2292426T3 (es) 2008-03-16
CN101046478B (zh) 2013-04-03
CN101046478A (zh) 2007-10-03
NO20013698L (no) 2001-09-28
KR100572542B1 (ko) 2006-04-24
EP1151304B1 (de) 2007-09-19
JP2003508724A (ja) 2003-03-04

Similar Documents

Publication Publication Date Title
IL144062A0 (en) METHOD OF IDENTIFYING N-TERMINAL proBNP
PL1625163T3 (pl) Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
EP1070255A4 (en) BIOLOGICAL ASSAY OF IGFBP COMPLEX
EP2172486A3 (en) Monoclonal antibody against a prion protein and its use for the detection of prions
EP1139101A3 (en) Immunoassay for c-reactive protein
ATE486093T1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
GR850899B (pl)
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
NO179107C (no) Monoklonalt antistoff for selektiv immunologisk bestemmelse av intakt prokollagen-peptid (type III) og prokollagen (type III) i kroppsvæsker, hybridom-cellelinje, anvendelse av antistoffene og diagnostiske sett
WO2003027149A1 (fr) Anticorps et utilisation de ce dernier
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
DE69112225D1 (de) Immunodiagnostische probe für gelenkrheumatismus.
EP1245957A3 (en) Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease
AU5039290A (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
Ishikawa et al. Novel and sensitive noncompetitive (two-site) immunoassay for haptens with emphasis on peptides
KR890012669A (ko) 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체
AU625398B2 (en) Monoclonal antibody recognizing gamma atrial natriuretic polypeptide
WO2000019207A3 (de) Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)
Englebienne et al. An improved method for isolation of specific antibodies by affinity chromatography; application to an antiserum to testosterone
ES8802262A1 (es) Procedimiento para la obtencion de un anticuerpo monoclonal contra la hormona luteinizante
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
Davis et al. The application of enzyme-linked immunosorbent assays (ELISA) to neuropeptides
AU6642698A (en) Immunoassay and kit for iga antibodies specific for acetaldehyde adducts
WO2004005489A3 (en) Nucleic acids encoding sarcocystic neurona antigen and uses thereof